Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
13.33
+0.04 (0.30%)
Nov 21, 2024, 4:00 PM EST - Market closed

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TAK.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Takeda Pharmaceutical.

Recommendation Trends

Rating Dec '22Jan '23Feb '23Mar '23Apr '23May '23
Strong Buy 000110
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 111220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
TD Cowen
TD Cowen
Buy
Maintains
$30$20
Buy Maintains $30$20 +50.04% May 16, 2023
TD Cowen
TD Cowen
Buy
Maintains
$24$30
Buy Maintains $24$30 +125.06% Apr 4, 2023
B of A Securities
B of A Securities
Strong Buy
Upgrades
$20
Strong Buy Upgrades $20 +50.04% Mar 16, 2023
Cowen & Co.
Cowen & Co.
Buy
Upgrades
$21$24
Buy Upgrades $21$24 +80.05% Jul 19, 2022
Cowen & Co.
Cowen & Co.
Hold
Initiates
$20
Hold Initiates $20 +46.29% Nov 1, 2019
More Analyst Ratings

Financial Forecast

Revenue This Year
4,451.79B
from 4,263.76B
Increased by 4.41%
Revenue Next Year
4,500.42B
from 4,451.79B
Increased by 1.09%
EPS This Year
77.98
from 91.16
Decreased by -14.46%
EPS Next Year
141.77
from 77.98
Increased by 81.80%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Mar 31, 2020 Mar 31, 2021 Mar 31, 2022 Mar 31, 2023 Mar 31, 2024 Mar 31, 2025 Mar 31, 2026 Mar 31, 2027
Revenue
3,291.19B3,197.81B3,569.01B4,027.48B4,263.76B4,451.79B4,500.42B4,563.77B
Revenue Growth
56.93%-2.84%11.61%12.85%5.87%4.41%1.09%1.41%
EPS
28.25238.96145.87201.9491.1677.98141.77188.34
EPS Growth
-79.80%745.88%-38.96%38.44%-54.86%-14.46%81.80%32.85%
Forward PE
-----26.4114.5310.94
No. Analysts -----191916
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 4.9T 4.9T 5.0T
Avg 4.5T 4.5T 4.6T
Low 4.1T 4.2T 4.2T

Revenue Growth

Revenue Growth 202420252026
High
14.1%
9.8%
10.5%
Avg
4.4%
1.1%
1.4%
Low
-3.0%
-4.9%
-6.5%

EPS Forecast

EPS 202420252026
High 146.59 260.51 284.13
Avg 77.98 141.77 188.34
Low 44.14 47.04 45.08

EPS Growth

EPS Growth 202420252026
High
60.8%
234.1%
100.4%
Avg
-14.5%
81.8%
32.9%
Low
-51.6%
-39.7%
-68.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.